(4-(Cyclopropylcarbamoyl)phenyl)boronic acid, 95.0%, 5g

10,11-DIHYDRODIBENZO[B,F][1,4]OXAZEPINE, 95.0%, 1g

N-[(4-BENZYLMORPHOLIN-2-YL)METHYL] -N-ETHYLETHANAMINE, 95.0%, 250mg

Flat flange reaction vial DURAN®, DN 150, 4000 ml, 184 mm, 200 mm, Height, 290 mm, 1 Piece

4-Acetylphenylboronic acid, 98.0%, 100g

g-Glu-Ala-OH, 99.0%, 1g

4-Bromo-6-chloro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 98%, 250mg

(R)-3-(4-Chloro-benzyloxy)-pyrrolidine hydrochloride, 250mg

(2E)-1-(2-methylpiperazin-1-yl)-3-phenylprop-2-en-1-one, 95.0%, 2g

(E)-3-(2,5-Dichlorophenyl)acrylic acid, 97%, 5g

Trichloroacetonitrile, 99.0%, 1kg

1-(2-ethylphenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 1g

Boc-DL-Cyclopentylglycine, 97.0%, 1g